Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 27, 2017
Pharmacy Choice - News - Generic Drugs - June 27, 2017

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 214     Next >>     Go To Page:

6/19/17 - Amgen And Allergan Announce FDA Advisory Committee Meeting To Review ABP 215, A Biosimilar Candidate To Bevacizumab
By a News Reporter-Staff News Editor at Pharma Business Week Amgen and Allergan plc. announced that the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration will review data supporting the Biologics License Application for ABP 215, a biosimilar candidate to Avastin , on July 13, 2017. The FDA has set a Biosimilar User Fee
6/19/17 - ERIS LIFESCIENCES PRIMARY OFFER: EXPENSIVE SOLUTION
The issue is an offer-for-sale by promoters and other shareholders in the price band of Rs600-603. However, the stock has been priced at a high premium even compared to India focussed MNC pharmaceutical subsidiaries. The company has a single production plant at Assam and this fact, along with price control and generic push by Government of India ar
6/19/17 - Global Generic Drugs Market 2017 to Surpass USD 652.6 Billion by 2021 - Orbis Research
OrbisResearch.com has published new research report on "Global Generic Drugs Market Research Report and Forecast to 2017-2022" to its database.. DALLAS, TEXAS, UNITED STATES, June 19, 2017/ EINPresswire.com/ Global Generic Drugs Market was worth USD 395.20 billion in 2016 and is expected to reach USD 652.6 billion by 2021 with a CAGR of 10.53%.
6/19/17 - GNW-News: Sandoz receives approval in Europe for Rixathon (biosimilar rituximab) to treat blood cancers and immunological diseases (english)
Sandoz receives approval in Europe for Rixathon to treat blood cancers and immunological diseases. Novartis International AG/ Sandoz receives approval in Europe for Rixathon to treat blood cancers and immunological diseases. Holzkirchen, June 19, 2017- Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced to
6/19/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 26488) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Oncologic Drugs Advisory Committee. Morning: Discuss biologics license application 761028 for ABP 215, a proposed biosimilar to Genentech/ Roche's AVASTIN, submitted by Amgen Inc., for the proposed indications/uses for the first- or second-line treatm
6/19/17 - Lannett Receives Approval For Niacin Extended-Release Tablets USP, 500 Mg And 1000 Mg
Lannett Company, Inc. today announced that it received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Niacin Extended-Release Tablets USP, 500 mg and 1000 mg, the therapeutic equivalent to the reference listed drug, Niaspan Extended-Release Tablets, 500 mg and 1000 mg, of AbbVie Inc. For the 12
6/19/17 - Noden Pharma Notified of ANDA Filing for Tekturna
By a News Reporter-Staff News Editor at Pharma Business Week PDL BioPharma, Inc. announced that its subsidiary, Noden Pharma DAC, received a Paragraph IV Notice Letter advising that Anchen Pharmaceuticals, Inc. submitted an Abbreviated New Drug Application to the United States Food and Drug Administration seeking authorization from the FDA to...
6/19/17 - OncBioMune Acquires Norepinefrine for Low Blood Pressure and Heart Failure in Mexico from Teva Pharmaceuticals Mexico
OncBioMune intends to immediately initiate distribution of Norepinefrine throughout its sales channels across Mexico. OncBioMune is conducting its due diligence with plans to selectively launch the drug in other markets in the future. "The acquisition of Norepinefrine adds the first big generic medicine to our Mexican product bag and we anticipate
6/19/17 - Sandoz receives approval in Europe for Rixathon (biosimilar rituximab) to treat blood cancers and immunological diseases
Novartis International AG/ Sandoz receives approval in Europe for Rixathon to treat blood cancers and immunological diseases. *Sandoz now has four biosimilars approved in Europe- more than any other company. Holzkirchen, June 19, 2017- Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced today that the Europea
6/19/17 - Sunshine Biopharma Files an Application with Health Canada for a Drug Establishment License
MONTREAL, QC/ ACCESSWIRE/ June 19, 2017/ Sunshine Biopharma Inc., a fully integrated pharmaceutical company offering generic and proprietary drugs for the treatment of cancer and other acute and chronic indications, is pleased to announce that it has filed an application for a Drug Establishment License with Health Canada, the Canadian equivalent o
6/18/17 - 5 Top NASDAQ Biotech Stocks: Ekso Bionics Gained 57.38 Percent
Newly appointed FDA commissioner Scott Gottlieb asked for public input when it comes to the current opioid crisis impacting the US. Ekso Bionics Holdings GTx Sorrento Therapeutics Adamis Pharmaceuticals EDAP TMS SA Ekso Bionics Holdings. Ekso Bionics Holdings gained 57.38 percent last week to finish at $1.92 per share.
6/18/17 - New Yorkers saved $21 billion with generic medications last year [Watertown Daily Times, N.Y.]
Despite increasing national attention to prescription price sticker-shock, a recent study found that in 2016 alone, New York state saved $21 billion by choosing generic prescription drugs over brand-name supplies. According to the Association for Accessible Medicines, nearly 90 percent of prescriptions nationally are filled by generics, while only.
6/17/17 - Adamis Gets FDA Nod for Generic Version of Mylan`s EpiPen [Sudan Tribune]
Shares of Adamis Pharmaceuticals Corporation ADMP soared more than 50% on Thursday after the FDA approved the company`s Epinephrine injection, USP, 1:10 00 which is the generic version of Mylan N.V. `s MYL EpiPen- the best-selling but high-cost treatment for life-threatening allergies. Adamis Pharmaceuticals` share price shows that the company has.
6/17/17 - Appointment Of Local Chemist For Supply Of Generic Drugs, Medicines, Surgical Consumables Etc. [TendersInfo (India)]
Tenders are invited for 1. Appointment of Local Chemist for supply of Generic Drugs, Medicines, Surgical consumables etc. last date- 28/06/2017 Major organization: GOVERNMENT OF NCT OF DELHI Address: Guru Teg Bahadur Hospital Dilshad Garden, Delhi -110095 Delhi Attn.: Dr.Sunil Kumar Medical Director Country: India Tender notice number: 2017 -GTB-13
6/17/17 - FDA chief Gottlieb maps out new digital health plan [Syrian Arab News Agency]
Gottlieb has moved quickly in his first month as FDA commissioner, surprising many with a request to Endo Pharmaceuticals to pull its opioid Opana ER from the market while also staking out positions on drug pricing and the approval process for generic drugs. However, current lack of clarity over which apps are covered by FDA regulation can leave de
6/17/17 - Tevas Generic HIV Drug Gains FDA Approval [Syrian Arab News Agency]
The FDA has approved Teva Pharmaceuticals generic version of Gileads HIV drug, Truvada,. We are pleased with the FDAs decision and look forward to supporting these patients with generic medicines when we are otherwise able to, said Elizabeth DeLuca, associate director of global generic medicines and North America for Teva. Eight years later, the FD
6/17/17 - The World Bank invests in Indian Biopharma [T-break Tech (Middle East)]
The Innovate in India for Inclusiveness mission, to which the World Bank has committed $125 m, will focus on a number of industry areas, including the development of early stage bio-manufacturing, vaccines, biosimilars, and medical devices. According to World Bank representatives Manju Haththotuwa and Jorge Coarasa, in order to build Indias industr
6/16/17 - Aspen loses Italy appeal over cancer drug prices
The Italian case relates to the prices of a portfolio of off-patent cancer drugs that Aspen acquired from GlaxoSmithKline several years ago, and that it recently increased. On Tuesday, the South African Competition Commission said it was launching an investigation into the price of cancer drugs, homing in on Aspen and multinational pharmaceutical..
6/16/17 - CBO Issues Cost Estimate for FDA Reauthorization Act
*Reauthorize certain programs and grants administered by FDA and the National Institutes of Health,. *Require the Government Accountability Office to report on FDA and NIH. Implementing S. 934 would require increased funding for a variety of FDA activities, but most of the increase in FDA spending would be offset by additional fees that would be co
6/16/17 - Findings from Winthrop University Hospital Provides New Data on Human Growth Hormone (Ten years of biosimilar recombinant human growth hormone in...
The news correspondents obtained a quote from the research from Winthrop University Hospital, "A biosimilar is defined by the European Medicines Agency as a biological medicine that is similar to another biological medicine that has already been authorized for use. The EMA led the way in developing the biosimilar concept, and the type of science-ba
6/16/17 - Findings on Cancer Risk Described by M.V. Borras Perez and Colleagues (Ten years of clinical experience with biosimilar human growth hormone: a...
Findings on Cancer Risk Described by M.V. Borras Perez and Colleagues. By a News Reporter-Staff News Editor at Drug Week Fresh data on Oncology- Cancer Risk are presented in a new report. According to news reporting out of Granollers, Spain, by NewsRx editors, research stated, "Safety concerns for recombinant human growth hormone treatments inclu
6/16/17 - Highlighting Bipartisan Plan to Lower Cost of Prescription Drugs, Collins, McCaskill Praise Food and Drug Administration Chief's Remarks
Washington, D.C.- U.S. Senators Susan Collins and Claire McCaskill were encouraged by recent remarks by the head of the Food and Drug Administration in support of solutions to help keep prescription drugs affordable and improve patients' access to medication, echoing the Senators' bipartisan efforts. "We share your commitment to increasing generic
6/16/17 - Key Themes Centred Around Regulation and New Market Dynamics at 8th Annual Biosimilars Industry Summit
Biosimilars 2017 draws from European experience to unveil new market access and commercialisation strategies for an evolving pharmaceutical landscape.
6/16/17 - Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg
Lannett Company, Inc. today announced that it received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Amantadine Hydrochloride Capsules USP, 100 mg, the therapeutic equivalent to the reference standard drug, Amantadine Hydrochloride Capsules USP, 100 mg, of Sandoz Pharmaceuticals. For the 12 months
6/16/17 - LUPIN LAUNCHES ANTIDEPRESSANT TABLETS IN US
Lupin, the drug manufacturer, has launched its antidepressant Bupropion Hydrochloride extended release tablets in the USA. The company had received approval from the United States Food and Drug Administration to launch these drugs. The drugs are generic versions of Wellbutrin XL tablets of Valeant Pharmaceuticals North America LLC.
Articles(s): 1 - 25 of 214     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415